These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16784793)

  • 1. Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery.
    Tang Q; Xu Y; Wu D; Sun Y; Wang J; Xu J; Deng F
    J Control Release; 2006 Aug; 114(1):41-6. PubMed ID: 16784793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica material TUD-1 as a drug delivery system.
    Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery.
    Li Z; Su K; Cheng B; Deng Y
    J Colloid Interface Sci; 2010 Feb; 342(2):607-13. PubMed ID: 19948346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
    Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM
    Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties.
    Contessotto L; Ghedini E; Pinna F; Signoretto M; Cerrato G; Crocellà V
    Chemistry; 2009 Nov; 15(44):12043-9. PubMed ID: 19774561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release.
    Kapoor S; Hegde R; Bhattacharyya AJ
    J Control Release; 2009 Nov; 140(1):34-9. PubMed ID: 19654029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery.
    Shen S; Chow PS; Chen F; Tan RB
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):985-91. PubMed ID: 17603186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release.
    Rehman F; Rahim A; Airoldi C; Volpe PLO
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective controlled release of captopril by silylation of mesoporous MCM-41.
    Qu F; Zhu G; Huang S; Li S; Qiu S
    Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
    Yang YJ; Tao X; Hou Q; Chen JF
    Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
    Yang P; Huang S; Kong D; Lin J; Fu H
    Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
    Song SW; Hidajat K; Kawi S
    Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
    Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
    Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier.
    Yang P; Quan Z; Hou Z; Li C; Kang X; Cheng Z; Lin J
    Biomaterials; 2009 Sep; 30(27):4786-95. PubMed ID: 19520428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol controlled release by mesoporous silica.
    Lopez T; Ortiz E; Alexander-Katz R; Basaldella E; Bokhimi X
    Nanomedicine; 2009 Jun; 5(2):170-7. PubMed ID: 19091634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
    Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
    J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of amorphous microporous silica for ibuprofen controlled release.
    Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
    Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sol-gel synthesis of a multifunctional, hierarchically porous silica/apatite composite.
    Andersson J; Areva S; Spliethoff B; Lindén M
    Biomaterials; 2005 Dec; 26(34):6827-35. PubMed ID: 15993485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.
    Yang P; Quan Z; Lu L; Huang S; Lin J
    Biomaterials; 2008 Feb; 29(6):692-702. PubMed ID: 17996294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible porous metal-organic frameworks for a controlled drug delivery.
    Horcajada P; Serre C; Maurin G; Ramsahye NA; Balas F; Vallet-Regí M; Sebban M; Taulelle F; Férey G
    J Am Chem Soc; 2008 May; 130(21):6774-80. PubMed ID: 18454528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.